Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management

W Ambrosius, S Michalak, W Kozubski… - International journal of …, 2020 - mdpi.com
Myelin oligodendrocyte glycoprotein (MOG)-associated disease (MOGAD) is a rare,
antibody-mediated inflammatory demyelinating disorder of the central nervous system …

Neuromyelitis optica

S Jarius, F Paul, BG Weinshenker, M Levy… - Nature Reviews …, 2020 - nature.com
Neuromyelitis optica (NMO; also known as Devic syndrome) is a clinical syndrome
characterized by attacks of acute optic neuritis and transverse myelitis. In most patients …

Clinical and neuroimaging findings in MOGAD–MRI and OCT

F Bartels, A Lu, FC Oertel, C Finke… - Clinical & …, 2021 - academic.oup.com
Myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are rare in
both children and adults, and have been recently suggested to be an autoimmune …

Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody‐positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody …

EC Li, Y Zheng, MT Cai, QL Lai, GL Fang, BQ Du… - …, 2022 - Wiley Online Library
Seizure is one of the manifestations of central nervous system inflammatory demyelinating
diseases, which mainly include multiple sclerosis (MS), aquaporin 4 antibody‐positive …

Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Behçet's syndrome

A Bettiol, M Becatti, E Silvestri… - Clinical & …, 2021 - academic.oup.com
Behçet's syndrome (BS) is a systemic vasculitis with several clinical manifestations.
Neutrophil hyperactivation mediates vascular BS pathogenesis, via both a massive reactive …

Immune mechanism of epileptogenesis and related therapeutic strategies

MJ Aguilar-Castillo, P Cabezudo-García… - Biomedicines, 2022 - mdpi.com
Immunologic and neuroinflammatory pathways have been found to play a major role in the
pathogenesis of many neurological disorders such as epilepsy, proposing the use of novel …

Clinical and imaging features of patients with encephalitic symptoms and myelin oligodendrocyte glycoprotein antibodies

J Wang, Z Qiu, D Li, X Yang, Y Ding, L Gao… - Frontiers in …, 2021 - frontiersin.org
Background Myelin oligodendrocyte glycoprotein-antibody (MOG-ab)-associated disease
(MOGAD) has highly heterogenous clinical and imaging presentations, in which encephalitis …

The cross talk between underlying mechanisms of multiple sclerosis and epilepsy may provide new insights for more efficient therapies

A Rayatpour, S Farhangi, E Verdaguer, J Olloquequi… - Pharmaceuticals, 2021 - mdpi.com
Despite the significant differences in pathological background of neurodegenerative
diseases, epileptic seizures are a comorbidity in many disorders such as Huntington …

[HTML][HTML] Myelin oligodendrocyte glycoprotein antibody-associated aseptic meningitis without neurological parenchymal lesions: A novel phenotype

S Lin, W Long, J Wen, Q Su, J Liao, Z Hu - Multiple Sclerosis and Related …, 2022 - Elsevier
Background Myelin oligodendrocyte glycoprotein (MOG) antibodies mediate inflammatory
demyelinating diseases of the central nervous system. This study aimed to understand the …

Serum neurofilament light chain in adult and pediatric patients with myelin oligodendrocyte glycoprotein antibody‐associated disease: correlation with relapses and …

W Luo, Y Chen, S Mao, J Jin, C Liu… - Journal of …, 2022 - Wiley Online Library
Myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) causes major
disability as a consequence of recurrent demyelinating events and neuronal loss …